Literature DB >> 25880437

Differential diagnosis of Bartter syndrome, Gitelman syndrome, and pseudo-Bartter/Gitelman syndrome based on clinical characteristics.

Natsuki Matsunoshita1, Kandai Nozu1, Akemi Shono1, Yoshimi Nozu1, Xue Jun Fu1, Naoya Morisada1, Naohiro Kamiyoshi1, Hiromi Ohtsubo1, Takeshi Ninchoji1, Shogo Minamikawa1, Tomohiko Yamamura1, Koichi Nakanishi2, Norishige Yoshikawa2, Yuko Shima2, Hiroshi Kaito1, Kazumoto Iijima1.   

Abstract

PURPOSE: Phenotypic overlap exists among type III Bartter syndrome (BS), Gitelman syndrome (GS), and pseudo-BS/GS (p-BS/GS), which are clinically difficult to distinguish. We aimed to clarify the differences between these diseases, allowing accurate diagnosis based on their clinical features.
METHODS: A total of 163 patients with genetically defined type III BS (n = 30), GS (n = 90), and p-BS/GS (n = 43) were included. Age at diagnosis, sex, body mass index, estimated glomerular filtration rate, and serum and urine electrolyte concentrations were determined.
RESULTS: Patients with p-BS/GS were significantly older at diagnosis than those with type III BS and GS. Patients with p-BS/GS included a significantly higher percentage of women and had a lower body mass index and estimated glomerular filtration rate than did patients with GS. Although hypomagnesemia and hypocalciuria were predominant biochemical findings in patients with GS, 17 and 23% of patients with type III BS and p-BS/GS, respectively, also showed these abnormalities. Of patients with type III BS, GS, and p-BS/GS, 40, 12, and 63%, respectively, presented with chronic kidney disease.
CONCLUSIONS: This study clarified the clinical differences between BS, GS, and p-BS/GS for the first time, which will help clinicians establish differential diagnoses for these three conditions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25880437     DOI: 10.1038/gim.2015.56

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  33 in total

1.  Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III.

Authors:  D B Simon; R S Bindra; T A Mansfield; C Nelson-Williams; E Mendonca; R Stone; S Schurman; A Nayir; H Alpay; A Bakkaloglu; J Rodriguez-Soriano; J M Morales; S A Sanjad; C M Taylor; D Pilz; A Brem; H Trachtman; W Griswold; G A Richard; E John; R P Lifton
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

2.  Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK.

Authors:  D B Simon; F E Karet; J Rodriguez-Soriano; J H Hamdan; A DiPietro; H Trachtman; S A Sanjad; R P Lifton
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

3.  Spectrum of mutations in Gitelman syndrome.

Authors:  Rosa Vargas-Poussou; Karin Dahan; Diana Kahila; Annabelle Venisse; Eva Riveira-Munoz; Huguette Debaix; Bernard Grisart; Franck Bridoux; Robert Unwin; Bruno Moulin; Jean-Philippe Haymann; Marie-Christine Vantyghem; Claire Rigothier; Bertrand Dussol; Michel Godin; Hubert Nivet; Laurence Dubourg; Ivan Tack; Anne-Paule Gimenez-Roqueplo; Pascal Houillier; Anne Blanchard; Olivier Devuyst; Xavier Jeunemaitre
Journal:  J Am Soc Nephrol       Date:  2011-03-17       Impact factor: 10.121

4.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

5.  A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes.

Authors:  Israel Zelikovic; Raymonde Szargel; Ali Hawash; Valentina Labay; Ihab Hatib; Nadine Cohen; Farid Nakhoul
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

6.  Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies.

Authors:  Melanie Peters; Nikola Jeck; Stephan Reinalter; Andreas Leonhardt; Burkhard Tönshoff; G ünter Klaus G; Martin Konrad; Hannsjörg W Seyberth
Journal:  Am J Med       Date:  2002-02-15       Impact factor: 4.965

7.  Kidney transplant in Gitelman's syndrome. Report of the first case.

Authors:  Lorenzo A Calò; Francesco Marchini; Paul A Davis; Paolo Rigotti; Elisa Pagnin; Andrea Semplicini
Journal:  J Nephrol       Date:  2003 Jan-Feb       Impact factor: 3.902

8.  Subjects heterozygous for genetic loss of function of the thiazide-sensitive cotransporter have reduced blood pressure.

Authors:  C Fava; M Montagnana; L Rosberg; P Burri; P Almgren; A Jönsson; P Wanby; G Lippi; P Minuz; L U Hulthèn; M Aurell; O Melander
Journal:  Hum Mol Genet       Date:  2007-11-01       Impact factor: 6.150

9.  SLC26A3 gene analysis in patients with Bartter and Gitelman syndromes and the clinical characteristics of patients with unidentified mutations.

Authors:  Shingo Ishimori; Hiroshi Kaito; Natsuki Matsunoshita; Hiromi Otsubo; Fusako Hashimoto; Takeshi Ninchoji; Kandai Nozu; Naoya Morisada; Kazumoto Iijima
Journal:  Kobe J Med Sci       Date:  2013-04-18

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  26 in total

1.  Eleven novel SLC12A1 variants and an exonic mutation cause exon skipping in Bartter syndrome type I.

Authors:  Yue Han; Xiangzhong Zhao; Sai Wang; Cui Wang; Dongxu Tian; Yanhua Lang; Irene Bottillo; Xinsheng Wang; Leping Shao
Journal:  Endocrine       Date:  2019-02-21       Impact factor: 3.633

2.  Congenital chloride diarrhea needs to be distinguished from Bartter and Gitelman syndrome.

Authors:  Natsuki Matsunoshita; Kandai Nozu; Masahide Yoshikane; Azusa Kawaguchi; Naoya Fujita; Naoya Morisada; Shingo Ishimori; Tomohiko Yamamura; Shogo Minamikawa; Tomoko Horinouchi; Keita Nakanishi; Junya Fujimura; Takeshi Ninchoji; Ichiro Morioka; Hiroaki Nagase; Mariko Taniguchi-Ikeda; Hiroshi Kaito; Kazumoto Iijima
Journal:  J Hum Genet       Date:  2018-05-30       Impact factor: 3.172

3.  Antenatal Bartter syndrome presenting with vomiting and constipation mimicking subacute intestinal obstruction in a 20-day-old neonate.

Authors:  Ibtihal Siddiq Abdelgadir; Fawzia Elgharbawy; Khalil Mohamad Salameh; Baha Eldin Juma
Journal:  BMJ Case Rep       Date:  2017-11-14

4.  Diagnostic strategy for inherited hypomagnesemia.

Authors:  Tomoko Horinouchi; Kandai Nozu; Naohiro Kamiyoshi; Koichi Kamei; Hiroko Togawa; Yuko Shima; Yoshimichi Urahama; Tomohiko Yamamura; Shogo Minamikawa; Keita Nakanishi; Junya Fujimura; Ichiro Morioka; Takeshi Ninchoji; Hiroshi Kaito; Koichi Nakanishi; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2017-03-01       Impact factor: 2.801

5.  Potassium Sensing by Renal Distal Tubules Requires Kir4.1.

Authors:  Catherina A Cuevas; Xiao-Tong Su; Ming-Xiao Wang; Andrew S Terker; Dao-Hong Lin; James A McCormick; Chao-Ling Yang; David H Ellison; Wen-Hui Wang
Journal:  J Am Soc Nephrol       Date:  2017-01-04       Impact factor: 10.121

6.  Clinical and Genetic Characterization of Patients with Bartter and Gitelman Syndrome.

Authors:  Viviana Palazzo; Valentina Raglianti; Samuela Landini; Luigi Cirillo; Carmela Errichiello; Elisa Buti; Rosangela Artuso; Lucia Tiberi; Debora Vergani; Elia Dirupo; Paola Romagnani; Benedetta Mazzinghi; Francesca Becherucci
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

7.  Mutation profile and treatment of Gitelman syndrome in Chinese patients.

Authors:  Fen Wang; Chuan Shi; Yunying Cui; Chunyan Li; Anli Tong
Journal:  Clin Exp Nephrol       Date:  2016-05-23       Impact factor: 2.801

8.  With no lysine kinase 4 modulates sodium potassium 2 chloride cotransporter activity in vivo.

Authors:  Andrew S Terker; Maria Castañeda-Bueno; Mohammed Z Ferdaus; Ryan J Cornelius; Kayla J Erspamer; Xiao-Tong Su; Lauren N Miller; James A McCormick; Wen-Hui Wang; Gerardo Gamba; Chao-Ling Yang; David H Ellison
Journal:  Am J Physiol Renal Physiol       Date:  2018-02-07

9.  Three Novel Homozygous Mutations of the SLC12A3 Gene in a Gitelman Syndrome Patient.

Authors:  Mei Zhong; Zhenwei Zhai; Xing Zhou; Jingxia Sun; Hui Chen; Wensheng Lu
Journal:  Int J Gen Med       Date:  2021-05-24

10.  Urinary Extracellular Vesicles for Renal Tubular Transporters Expression in Patients With Gitelman Syndrome.

Authors:  Chih-Chien Sung; Min-Hsiu Chen; Yi-Chang Lin; Yu-Chun Lin; Yi-Jia Lin; Sung-Sen Yang; Shih-Hua Lin
Journal:  Front Med (Lausanne)       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.